Antares Pharma, Inc. (ATRS)

Accounts Payable

$19.88M

Quarterly · Period ending: · USD

ATRS logo

ATRS Accounts Payable

Latest reported$19.88M
ATRS Quarterly Accounts Payable ($200.00K → $19.88M)
High-resolution chart · PNG

ATRS accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
19,878,000
17,056,000
12,885,000
15,797,000
16,764,000
16,194,000
18,016,000
18,071,000
18,184,000
12,905,000
16,530,000
11,699,000
15,622,000
11,135,000
7,497,000
6,577,000
6,652,000
5,957,000
8,245,154
8,478,038
8,687,427
7,884,983
8,096,400
10,825,215
6,960,444
5,187,703
2,392,929
4,762,221
8,852,636
10,071,504
8,030,911
6,461,140
5,679,990
6,378,712
4,689,615
5,180,913
3,171,717
2,864,507
2,819,932
2,617,635
2,927,365
2,139,130
1,829,387
2,285,439
1,972,744
1,773,259
1,578,602
1,161,762
2,008,304
1,882,158
1,887,786
2,201,508
2,554,330
2,103,493
2,000,136
2,797,539
2,179,733
804,848
1,320,858
1,030,284
1,335,515
813,014
764,717
1,109,430
689,135
945,028
563,549
429,062
435,100
476,509
541,993
315,201
511,476
253,336
264,807
847,414
937,025
608,695
487,575
644,429
594,124
637,794
518,651
639,175
855,020
779,900
176,729
207,335
591,033
337,927
400,000
300,000
300,000
250,512
200,000
200,000
500,000
321,758
200,000
200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.